Administrative Core
行政核心
基本信息
- 批准号:10237162
- 负责人:
- 金额:$ 27.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-19 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAnnual ReportsApplications GrantsAuthorshipAwardBudgetsClinicCommunicationContractsCore GrantDataDevelopmentDiagnosisEnsureEvaluationExperimental DesignsFeedbackFundingFunding OpportunitiesFutureGoalsGrantGuidelinesHuman ResourcesInfrastructureIntellectual PropertyIowaKnowledgeLeadershipLegal patentLymphomaManuscriptsMedicalMolecular DiagnosisMonitorNIH Program AnnouncementsPreparationPrincipal InvestigatorPrognosisProgram Research Project GrantsProgress ReportsReportingReproducibilityResearchResearch PersonnelResource SharingResourcesRunningScheduleScienceSiteSpecialistStructureSumSupervisionTalentsTelephoneUniversitiesVisionWorkcohesionexperienceinventionmeetingsmemberpostersprogramsresponsesuccesstherapeutic targettranslational scientisttrend
项目摘要
The Administrative Core (Dr. Rimsza) will provide the strategic leadership, organization, communication, and
fiscal management of the grant. The Core will support the grant through the following Specific Aims/Goals:
(1) To provide strategic leadership of the grant including the initiation, coordination, and successful submission
of this P01 grant, ensuring rigor and reproducibility in experimental design and core activities, and evaluating
on-going program announcements for additional funding for spin-off and developmental work. (2) To provide
feedback on progress and direction of Projects and Cores via requiring semi-annual presentations from each
Project and Core to evaluate their progress, discussing difficulties and planning new directions; convening the
internal Steering Committee and External Advisory Board, and monitoring and suggesting adaptations in
response to emerging scientific trends. (3) To coordinate communication by scheduling and running the
monthly LLMPP Steering Committee calls (setting the agenda, recording and distributing minutes), maintaining
membership list with contact information, organizing the semi-annual meetings (WebEx and face-to-face), and
preparing the annual progress report for the NCI. Communication functions will also include overseeing
preparation and submission of abstracts, posters, and manuscripts, including issues related to authorship.
Finally, the core will oversee any intellectual property issues (several patents were previously filed on behalf of
the LLMPP by the NCI); and (4) To oversee fiscal matters by working with PIs on the initial and 5-year budgets
and budget justifications, overseeing preparation of the sub-contracts to the different sites, monitoring
spending, approving invoices, and re-assigning funds as needed. Dr. Lisa Rimsza will be the Principal
Investigator of the Administrative Core and grant overall, as well as a co-PI on Project 1 and co-investigator on
Project 4. She has served as the LLMPP overall Principal Investigator for the last 7 years including
submission and successful funding of the prior LLMPP grant and spin-off grants, and is now leading the current
grant application after unanimous re-election as the continued overall Principal Investigator by the LLMPP
members. In addition to her scientific credentials, she is highly experienced in all aspects of scientific grant
management. The impact of this Core will be the smooth functioning of this already highly successful research
consortium, making the best use of resources and talent, and ensuring cohesion to achieve the stated scientific
and medical goals. She is supported by a strong infrastructure in the Office of Sponsored Projects
Administration at the Mayo Clinic including pre-award and post-award specialists, accounting, and liaisons with
the University of Iowa-Mayo Clinic Lymphoma SPORE grant’s Biospecimen shared resource.
行政核心(Rimsza博士)将提供战略领导、组织、沟通和
赠款的财务管理。核心将通过以下具体目的/目标支持赠款:
(1)提供赠款的战略领导,包括发起、协调和成功提交
确保实验设计和核心活动的严格性和可重复性,并评价
正在进行的计划公告,为衍生和开发工作提供额外资金。(2)提供
通过要求每个项目和核心项目每半年提交一次报告,反馈项目和核心项目的进展和方向
项目和核心评估其进展,讨论困难并规划新的方向;召开
内部指导委员会和外部咨询委员会,以及监测和建议在
对新兴科学趋势的回应。(3)通过调度和运行
每月LLMPP指导委员会会议(设置议程,记录和分发会议纪要),维护
带有联系信息的成员名单,组织半年一次的会议(WebEx和面对面),以及
为NCI准备年度进度报告。通信功能还将包括监督
准备和提交摘要、海报和手稿,包括与作者身份有关的问题。
最后,该核心将监督任何知识产权问题(之前代表
NCI的LLMPP);以及(4)通过与私人投资机构就初始预算和5年预算进行合作,监督财政事务
和预算理由,监督不同地点分包合同的准备,监测
根据需要支出、审批发票和重新分配资金。丽莎·里姆萨博士将担任校长
行政核心和赠款总体调查员,以及项目1的联合PI和项目1的联合调查员
项目4.她在过去7年一直担任LLMPP的总体首席调查员,包括
提交并成功资助了之前的LLMPP赠款和剥离赠款,现在领导着目前的
LLMPP一致连任总首席调查员后批准申请
会员。除了她的科学资历,她在科学资助的各个方面都非常有经验。
管理层。这一核心的影响将是这项已经非常成功的研究的顺利运作
联盟,充分利用资源和人才,并确保凝聚力,以实现所述的科学
和医学目标。她得到了赞助项目办公室强大的基础设施的支持
梅奥诊所的行政管理,包括获奖前和获奖后的专家,会计,以及与
爱荷华大学梅奥诊所淋巴瘤孢子赠款的生物量共享资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lisa Rimsza其他文献
Lisa Rimsza的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lisa Rimsza', 18)}}的其他基金
Molecular Diagnosis, Prognosis, and Therapeutic Targets in Lymphoma
淋巴瘤的分子诊断、预后和治疗靶点
- 批准号:
9788307 - 财政年份:2018
- 资助金额:
$ 27.61万 - 项目类别:
Development of Mantle Cell Lymphoma Proliferation Signature Assay
套细胞淋巴瘤增殖特征检测的发展
- 批准号:
9981868 - 财政年份:2017
- 资助金额:
$ 27.61万 - 项目类别:
Development of Mantle Cell Lymphoma Proliferation Signature Assay
套细胞淋巴瘤增殖特征检测的发展
- 批准号:
9535251 - 财政年份:2017
- 资助金额:
$ 27.61万 - 项目类别:
Development of Mantle Cell Lymphoma Proliferation Signature Assay
套细胞淋巴瘤增殖特征检测的发展
- 批准号:
10223219 - 财政年份:2017
- 资助金额:
$ 27.61万 - 项目类别:
Molecular Diagnosis and Prognosis in Aggressive Lymphoma
侵袭性淋巴瘤的分子诊断和预后
- 批准号:
9191003 - 财政年份:2011
- 资助金额:
$ 27.61万 - 项目类别:
Molecular Diagnosis and Prognosis in Aggressive Lymphoma
侵袭性淋巴瘤的分子诊断和预后
- 批准号:
8090721 - 财政年份:2011
- 资助金额:
$ 27.61万 - 项目类别:
Molecular Diagnosis and Prognosis in Aggressive Lymphoma
侵袭性淋巴瘤的分子诊断和预后
- 批准号:
8307807 - 财政年份:2011
- 资助金额:
$ 27.61万 - 项目类别:
Molecular Diagnosis and Prognosis in Aggressive Lymphoma
侵袭性淋巴瘤的分子诊断和预后
- 批准号:
8686600 - 财政年份:2011
- 资助金额:
$ 27.61万 - 项目类别:
相似海外基金
Culture change in international organizations: Exammining corporate annual reports of Japanese and US corporations
国际组织的文化变迁:审视日本和美国企业的年度报告
- 批准号:
20K01874 - 财政年份:2020
- 资助金额:
$ 27.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of the value of textual information in annual reports through natural language processing
通过自然语言处理分析年报文本信息的价值
- 批准号:
18K18566 - 财政年份:2018
- 资助金额:
$ 27.61万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Analysing Narrative Aspects of UK Preliminary Earnings Announcements and Annual Reports: Tools and Insights for Researchers and Regulators
分析英国初步收益公告和年度报告的叙述方面:研究人员和监管机构的工具和见解
- 批准号:
ES/R003904/1 - 财政年份:2017
- 资助金额:
$ 27.61万 - 项目类别:
Research Grant
The Design of Corporate Annual Reports in London, 1980-2000
1980-2000 年伦敦公司年度报告的设计
- 批准号:
1937453 - 财政年份:2017
- 资助金额:
$ 27.61万 - 项目类别:
Studentship
Making a database of statistical appendices to Annual Reports of the Poor Law Commissioners and those of the Poor Law Board and the analysis of the database.
建立济贫法专员和济贫法委员会年度报告的统计附录数据库,并对数据库进行分析。
- 批准号:
16530240 - 财政年份:2004
- 资助金额:
$ 27.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Econological Approach toward Annual Reports
年度报告的经济方法
- 批准号:
07630123 - 财政年份:1995
- 资助金额:
$ 27.61万 - 项目类别:
Grant-in-Aid for Scientific Research (C)